164 related articles for article (PubMed ID: 29643753)
1. Reefer to the Rescue: The Dope on Cannabidiol as a Multi-Symptom Panacea for Dravet Syndrome.
Gupta A; Santhakumar V
Epilepsy Curr; 2018; 18(2):118-120. PubMed ID: 29643753
[No Abstract] [Full Text] [Related]
2. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice.
Patra PH; Serafeimidou-Pouliou E; Bazelot M; Whalley BJ; Williams CM; McNeish AJ
Br J Pharmacol; 2020 Jun; 177(12):2779-2792. PubMed ID: 32321192
[TBL] [Abstract][Full Text] [Related]
4. Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial.
Miller I; Scheffer IE; Gunning B; Sanchez-Carpintero R; Gil-Nagel A; Perry MS; Saneto RP; Checketts D; Dunayevich E; Knappertz V;
JAMA Neurol; 2020 May; 77(5):613-621. PubMed ID: 32119035
[TBL] [Abstract][Full Text] [Related]
5. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Devinsky O; Cross JH; Laux L; Marsh E; Miller I; Nabbout R; Scheffer IE; Thiele EA; Wright S;
N Engl J Med; 2017 May; 376(21):2011-2020. PubMed ID: 28538134
[TBL] [Abstract][Full Text] [Related]
6. The adult motor phenotype of Dravet syndrome is associated with mutation of the STXBP1 gene and responds well to cannabidiol treatment.
Álvarez Bravo G; Yusta Izquierdo A
Seizure; 2018 Aug; 60():68-70. PubMed ID: 29929108
[TBL] [Abstract][Full Text] [Related]
7. A novel GABAergic dysfunction in human Dravet syndrome.
Ruffolo G; Cifelli P; Roseti C; Thom M; van Vliet EA; Limatola C; Aronica E; Palma E
Epilepsia; 2018 Nov; 59(11):2106-2117. PubMed ID: 30306542
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.
Kaplan JS; Stella N; Catterall WA; Westenbroek RE
Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11229-11234. PubMed ID: 28973916
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.
Lattanzi S; Trinka E; Russo E; Striano P; Citraro R; Silvestrini M; Brigo F
Drugs Today (Barc); 2019 Mar; 55(3):177-196. PubMed ID: 30938373
[TBL] [Abstract][Full Text] [Related]
10. Real-world evidence on the use of cannabidiol for the treatment of drug resistant epilepsy not related to Lennox-Gastaut syndrome, Dravet syndrome or Tuberous Sclerosis Complex.
Espinosa-Jovel C; Riveros S; Bolaños-Almeida C; Salazar MR; Inga LC; Guío L
Seizure; 2023 Nov; 112():72-76. PubMed ID: 37769547
[TBL] [Abstract][Full Text] [Related]
11. Caregivers' Perspectives on the Impact of Cannabidiol (CBD) Treatment for Dravet and Lennox-Gastaut Syndromes: A Multinational Qualitative Study.
Marshall J; Skrobanski H; Moore-Ramdin L; Kornalska K; Swinburn P; Bowditch S
J Child Neurol; 2023 May; 38(6-7):394-406. PubMed ID: 37455396
[TBL] [Abstract][Full Text] [Related]
12. Dravet Syndrome: A Review of Current Management.
Wheless JW; Fulton SP; Mudigoudar BD
Pediatr Neurol; 2020 Jun; 107():28-40. PubMed ID: 32165031
[TBL] [Abstract][Full Text] [Related]
13. Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: An indirect treatment comparison.
Devi N; Madaan P; Asrar MM; Sahu JK; Bansal D
Seizure; 2021 Oct; 91():316-324. PubMed ID: 34274891
[TBL] [Abstract][Full Text] [Related]
14. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
[TBL] [Abstract][Full Text] [Related]
15. Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome.
Lattanzi S; Zaccara G; Russo E; La Neve A; Lodi MAM; Striano P
Expert Rev Neurother; 2021 Jan; 21(1):99-110. PubMed ID: 33026899
[TBL] [Abstract][Full Text] [Related]
16. A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2022 Mar; 36(3):217-237. PubMed ID: 35156171
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea.
Koo CM; Kim SH; Lee JS; Park BJ; Lee HK; Kim HD; Kang HC
J Korean Med Sci; 2020 Dec; 35(50):e427. PubMed ID: 33372424
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
[TBL] [Abstract][Full Text] [Related]
19. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Tang R; Fang F
N Engl J Med; 2017 Aug; 377(7):699. PubMed ID: 28816426
[No Abstract] [Full Text] [Related]
20. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Devinsky O; Cross JH; Wright S
N Engl J Med; 2017 Aug; 377(7):699-700. PubMed ID: 28813226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
